KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Assets (2016 - 2025)

Resmed (RMD) has disclosed Assets for 16 consecutive years, with $8.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets rose 19.07% year-over-year to $8.5 billion, compared with a TTM value of $8.5 billion through Dec 2025, up 19.07%, and an annual FY2025 reading of $8.2 billion, up 18.95% over the prior year.
  • Assets was $8.5 billion for Q4 2025 at Resmed, up from $8.3 billion in the prior quarter.
  • Across five years, Assets topped out at $8.5 billion in Q4 2025 and bottomed at $4.6 billion in Q1 2021.
  • Average Assets over 5 years is $6.4 billion, with a median of $6.7 billion recorded in 2023.
  • The sharpest move saw Assets grew 1.67% in 2021, then skyrocketed 41.0% in 2022.
  • Year by year, Assets stood at $4.7 billion in 2021, then skyrocketed by 41.0% to $6.7 billion in 2022, then rose by 3.43% to $6.9 billion in 2023, then rose by 3.42% to $7.1 billion in 2024, then increased by 19.07% to $8.5 billion in 2025.
  • Business Quant data shows Assets for RMD at $8.5 billion in Q4 2025, $8.3 billion in Q3 2025, and $8.2 billion in Q2 2025.